BrainCool Past Earnings Performance
Past criteria checks 0/6
BrainCool's earnings have been declining at an average annual rate of -4%, while the Medical Equipment industry saw earnings growing at 21.2% annually. Revenues have been growing at an average rate of 22.2% per year.
Key information
-4.0%
Earnings growth rate
29.3%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 22.2% |
| Return on equity | -37.4% |
| Net Margin | -137.1% |
| Next Earnings Update | 10 Feb 2025 |
Recent past performance updates
Recent updates
Is BrainCool (NGM:BRAIN) In A Good Position To Invest In Growth?
Mar 24
Here's Why BrainCool (NGM:BRAIN) Can Afford Some Debt
Nov 17We Think BrainCool (NGM:BRAIN) Has A Fair Chunk Of Debt
Jul 23Is BrainCool (NGM:BRAIN) A Risky Investment?
Mar 07How Much Did BrainCool's(NGM:BRAIN) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 14Revenue & Expenses Breakdown
How BrainCool makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 42 | -58 | 59 | 0 |
| 30 Jun 24 | 36 | -57 | 61 | 0 |
| 31 Mar 24 | 33 | -57 | 62 | 0 |
| 31 Dec 23 | 27 | -61 | 63 | 0 |
| 30 Sep 23 | 32 | -52 | 60 | 0 |
| 30 Jun 23 | 32 | -53 | 60 | 0 |
| 31 Mar 23 | 28 | -52 | 59 | 0 |
| 31 Dec 22 | 30 | -46 | 57 | 0 |
| 30 Sep 22 | 16 | -48 | 59 | 0 |
| 30 Jun 22 | 19 | -44 | 56 | 0 |
| 31 Mar 22 | 34 | -42 | 63 | 0 |
| 31 Dec 21 | 23 | -39 | 50 | 0 |
| 30 Sep 21 | 25 | -34 | 45 | 0 |
| 30 Jun 21 | 22 | -33 | 43 | 0 |
| 31 Mar 21 | 8 | -32 | 30 | 0 |
| 31 Dec 20 | 16 | -37 | 38 | 0 |
| 30 Sep 20 | 17 | -46 | 44 | 0 |
| 30 Jun 20 | 15 | -50 | 47 | 0 |
| 31 Mar 20 | 14 | -57 | 53 | 0 |
| 31 Dec 19 | 12 | -57 | 53 | 0 |
| 30 Sep 19 | 13 | -55 | 50 | 0 |
| 30 Jun 19 | 10 | -51 | 47 | 0 |
| 31 Mar 19 | 7 | -44 | 41 | 0 |
| 31 Dec 18 | 9 | -39 | 36 | 0 |
| 30 Sep 18 | 7 | -28 | 29 | 0 |
| 30 Jun 18 | 6 | -25 | 25 | 0 |
| 31 Mar 18 | 4 | -22 | 22 | 0 |
| 31 Dec 17 | 5 | -23 | 22 | 0 |
| 30 Sep 17 | 4 | -21 | 23 | 0 |
| 30 Jun 17 | 3 | -20 | 22 | 0 |
| 31 Mar 17 | 3 | -18 | 20 | 0 |
| 31 Dec 16 | 3 | -13 | 17 | 0 |
| 30 Sep 16 | 3 | -12 | 14 | 0 |
| 30 Jun 16 | 3 | -12 | 14 | 0 |
| 31 Mar 16 | 2 | -11 | 13 | 0 |
| 31 Dec 15 | 2 | -9 | 12 | 0 |
| 30 Sep 15 | 2 | -13 | 10 | 0 |
| 30 Jun 15 | 1 | -11 | 8 | 0 |
| 31 Mar 15 | 1 | -10 | 6 | 0 |
| 31 Dec 14 | 0 | -9 | 4 | 0 |
| 30 Sep 14 | 0 | -3 | 3 | 0 |
| 30 Jun 14 | 0 | -1 | 1 | 0 |
| 31 Mar 14 | 0 | 0 | 0 | 0 |
Quality Earnings: BRAIN is currently unprofitable.
Growing Profit Margin: BRAIN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BRAIN is unprofitable, and losses have increased over the past 5 years at a rate of 4% per year.
Accelerating Growth: Unable to compare BRAIN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BRAIN is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.2%).
Return on Equity
High ROE: BRAIN has a negative Return on Equity (-37.43%), as it is currently unprofitable.